Pharmaceuticals Spared, But Medical Devices to Face Section 301 Tariffs on July 6
Pharmaceuticals appear to have been spared from the first round of Section 301 tariffs, but medical devices and equipment remain on the final list. The U.S. will begin collecting an additional 25 percent in tariffs on 818 lines of the original 1,333 tariff lines proposed in April, the Office of the U.S. Trade Representative announced June 15. Tariff collection will begin July 6.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
There are 29 tariff code lines in chapters 9018, 9021 and 9022 that are on the list, including electrocardiographs and parts for those machines; MRI machines, anesthetic instruments, electro-surgical instruments, pacemakers, X-rays and radiation beam delivery units.
A second group of potential targets, related to the Made in China 2025 initiative, will have a round of public comments, including a public hearing, before a final decision is made. Those products include 284 lines from the Harmonized Tariff Schedule. The government will offer an product exclusion request process, but no details were offered in the USTR announcement.